DDInter1652 DDInter1966
Secukinumab is a fully human monoclonal IgG1/κ antibody against interleukin-17A (IL-17A), a proinflammatory cytokine implicated in various chronic immune-mediated inflammatory disorders, such as plaque psoriasis. By blocking the actions of IL-17A, secukinumab works to inhibit the pro-inflammatory pathways that drive immune-mediated inflammatory disorders. Following its first global approval in Japan in December 2014, secukinumab was approved by the European Commission on January 15, 2015, and by the FDA a few days after (January 21, 2015). It is currently approved to treat a number of chronic inflammatory conditions, such as plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and hidradenitis suppurativa.[L39600,L42280,L48771]
Zinc sulfate is the inorganic compound with the formula ZnSO4 and historically known as "white vitriol". It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.
Zinc sulfate {u} may cause a minor interaction that can limit clinical effects when taken with {v} Efalizumab
Zinc sulfate {u} may cause a minor interaction that can limit clinical effects when taken with {v} Ixekizumab
Zinc sulfate {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Trovafloxacin
Zinc sulfate {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Baloxavir marboxil
Zinc sulfate {u} may lead to a major life threatening interaction when taken with {v} Raltegravir
Zinc sulfate may cause a minor interaction that can limit clinical effects when taken with Efalizumab
Zinc sulfate may cause a minor interaction that can limit clinical effects when taken with Ixekizumab
Zinc sulfate may cause a moderate interaction that could exacerbate diseases when taken with Trovafloxacin
Zinc sulfate may cause a moderate interaction that could exacerbate diseases when taken with Baloxavir marboxil
Zinc sulfate may lead to a major life threatening interaction when taken with Raltegravir